
PE 22-28 spadin-derived heptapeptide, 8 mg lyophilized at 98.6% HPLC purity.
PE 22-28 is a short spadin analogue studied as a TREK-1 channel reference ligand in neuroscience models. Every PureLabs lot of PE 22-28 is produced under GMP-aligned synthesis controls, assayed by an independent partner laboratory using reverse-phase HPLC with mass-spectrometric confirmation, and released only above the stated purity threshold of 98.6%. The certificate of analysis is lot-specific, carries the chromatogram and MS trace for the exact vial you receive, and stays archived under reference SEQ-1120 for as long as the batch exists.
Common laboratory questions about sourcing, purity, storage and shipping of PE 22-28.
Current stock assays at 98.6% by reverse-phase HPLC, confirmed by mass spectrometry at an independent laboratory. Any lot testing below the threshold is rejected rather than sold.
Yes. A lot-specific certificate of analysis including the HPLC chromatogram and MS trace accompanies every PE 22-28 order and remains retrievable under batch reference SEQ-1120.
Sealed lyophilized PE 22-28 is stable at −20 °C for at least 24 months; once reconstituted, hold at 2–8 °C and use within about three weeks.
Orders confirmed before 15:00 UTC dispatch the same working day in insulated, tracked cold-chain packaging, subject to the import rules of the destination country.
No. PureLabs supplies this compound strictly as reference material for in-vitro and laboratory research. It is not a medicine and is not for human or veterinary consumption.